At a Glance
| Flubromazolam | 2M2B | |
|---|---|---|
| Class | Depressant | Depressant |
| Common Dose (oral) | 150–250 μg | 5–10 mL |
| Total Duration | — | 6–8 hrs |
| Routes | oral | oral |
| Effects |
Dangerous Combination
Combining Flubromazolam and 2M2B is classified as dangerous. Combined CNS depression; risk of respiratory failure
Flubromazolam, a Depressant, and 2M2B, a Depressant, are frequently compared by users looking to understand their relative effects, dosage profiles, and safety considerations. Both are classified as Depressants, meaning they share a common pharmacological foundation. They share 10 documented effects in common, with 1 effects unique to Flubromazolam and 13 unique to 2M2B. This side-by-side comparison covers dosage, duration, subjective effects, and safety to help you make informed decisions.
| Flubromazolam | 2M2B | |
|---|---|---|
| Class | Depressant | Depressant |
| Common Dose (oral) | 150–250 μg | 5–10 mL |
| Total Duration | — | 6–8 hrs |
| Routes | oral | oral |
| Effects |
| 11 documented |
| 23 documented |
| Interaction | Dangerous | |
| Level | Flubromazolam | 2M2B |
|---|---|---|
| Threshold | 50 μg | 0.5 mL |
| Light | 100–150 μg | 1–5 mL |
| Common | 150–250 μg | 5–10 mL |
| Strong | 250–400 μg | 10–15 mL |
| Heavy | 400 μg | 15 mL |
Flubromazolam
2M2B
Total: 8 hrs – 14 hrs
Combined CNS depression; risk of respiratory failure